INVO Fertility, Inc

IVF

Healthcare Medical Devices

INVO Fertility, Inc’s revenue for fiscal 2025 (year ended December 2025) was $6.8 million, up 4.74% from fiscal 2024.

Revenue
+16.7%
EPS
+100.1%
Free cash flow
+35.1%
Total debt
−50.7%

Quarter to June 2026, against a year earlier

2.14 0.11 +5.42%
Market cap
$2.6M
P/E
n/m
Fwd P/E
n/m
Dividend yield
—
F-score
4/9
ROIC
−27.9%
Net debt / EBITDA
0.2×
Dividend safety
n/a
Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
P/E ratio
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Piotroski F-Score
4 4 4 7 5 5 2 5 4 4
P/S ratio
883,505,236.93 69,243,011.43 115,368,949.17 26.92 66.85 9.22 6.15 5.31 3.54 0.81
Altman Z-Score
5,492,046.57 2,302,209.30 9,771,514.27 (17.39) 3.21 1.42 (26.40) (5.59) (2.60) (7.54)
Altman Z″-Score (non-manufacturers)
(358.54) (365.79) (138.07) (50.60) (6.88) (9.86) (68.02) (14.98) (7.70) (19.01)
P/FCF ratio
0.00 0.00 0.00 30.52 0.00 0.00 0.00 0.00 0.00 0.00
Beneish M-Score
(30.06) (3.39) (16.27) (8.55) (1.80) 4.79 — (1.59) (2.46) (1.33)
P/Operating CF
(455,655,492.75) (1,001,715,565.31) (199,116,171.69) (51.68) (38.10) (25.39) (5.04) (22.43) (37.47) 219.30
P/B ratio
0.00 0.00 0.00 0.00 12.08 5.25 0.00 0.00 0.00 1.15
EV/Sales
883,505,236.72 69,243,011.84 115,368,949.44 26.34 57.69 8.37 9.28 6.34 4.41 0.63
EV/EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EV/FCF
(138,567,662.94) (107,741,057.03) (87,330,584.54) 29.86 (12.30) (5.34) (1.15) (3.68) (9.34) (0.62)
Current Ratio
0.05 0.05 0.21 1.03 4.61 5.03 0.19 0.16 0.07 0.27
Net Debt/EBITDA
0.01 (0.50) 0.02 0.61 3.18 0.98 (0.15) (0.17) (0.10) 0.25
Debt/Equity
(0.03) (0.07) (0.06) (0.10) 0.10 0.26 (1.71) 1.40 0.09 0.10
ROE
50.73% 14.61% 79.73% 67.34% (822.60%) (101.96%) (343.99%) 264.08% 83.06% 387.43%
ROA
(490.60%) (254.14%) (589.46%) (168.49%) (131.01%) (62.16%) (153.67%) (72.33%) (29.45%) (75.81%)
ROIC
0.00% 0.00% 0.00% 0.00% 0.00% (92.43%) (1,102.70%) (220.95%) (31.64%) (76.78%)
Return on Tangible Assets
47.15% 14.40% 112.43% (1,600.81%) (99.53%) (119.82%) 477.70% 135.80% 58.90% 349.81%
Average Days of Receivables
20.08 112.18 166.77 1.87 7.64 4.43 34.23 16.99 6.32 11.59
Earnings Yield
0.00% 0.00% 0.00% (2.83%) (12.68%) (18.83%) (205.06%) (164.07%) (69.03%) (25,777.41%)
Free Cash Flow Yield
0.00% 0.00% 0.00% 3.28% (7.01%) (16.98%) (130.79%) (32.43%) (13.33%) (127.75%)
Free Cash Flow per Share
0.00 0.00 0.00 7,449.72 (24,320.50) (16,211.25) (16,540.00) (5,199.80) (1,226.13) (60.32)
Book value per Share
(0.03) (0.04) (0.02) (22,030.02) 28,715.50 18,276.75 (2,444.00) 892.60 5,005.73 61.75
Free Cash Flow
(0.34) (0.18) (0.67) 1.26 (4.86) (6.48) (6.62) (5.20) (3.08) (7.06)
EV/EBIT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other line items

Show all line items

Columns are period end dates · fundamentals updated 26 Oct 2026